References:
1. Hansen CL, Chaves SS, Demont C, Viboud C. Mortality associated with influenza and respiratory syncytial virus in the US, 1999-2018. JAMA Network Open. 2022;5(2):e220527-e.
2. Organization WH. Global Influenza Strategy 2019-2030. 2020.
3. Thommes EW, Kruse M, Kohli M, Sharma R, Noorduyn SG. Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines. Human vaccines & immunotherapeutics. 2017;13(4):867-76.
4. Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, et al. The disease burden of influenza beyond respiratory illness. Vaccine. 2021;39:A6-A14.
5. Organization WH. Cardiovascular diseases (CVDs) Fact sheet: World Health Organization; 2017 [Available from: http://www.who.int/mediacentre/factsheets/fs317/en/.
6. Bowry AD, Lewey J, Dugani SB, Choudhry NK. The burden of cardiovascular disease in low-and middle-income countries: epidemiology and management. Canadian Journal of Cardiology. 2015;31(9):1151-9.
7. Miranda JJ, Barrientos-Gutierrez T, Corvalan C, Hyder AA, Lazo-Porras M, Oni T, et al. Understanding the rise of cardiometabolic diseases in low-and middle-income countries. Nature medicine. 2019;25(11):1667-79.
8. Arnold N, Lechner K, Waldeyer C, Shapiro MD, Koenig W. Inflammation and cardiovascular disease: the future. European Cardiology Review. 2021;16.
9. Stewart S, Keates AK, Redfern A, McMurray JJ. Seasonal variations in cardiovascular disease. Nature Reviews Cardiology. 2017;14(11):654-64.
10. Hernández EG, O’Callaghan AC, Doménech JC, Merino VL, Mañez RS, Errazti IE, et al. Seasonal variations in admissions for acute myocardial infarction. The PRIMVAC study. Revista Española de Cardiología (English Edition). 2004;57(1):12-9.
11. Madjid M, Miller CC, Zarubaev VV, Marinich IG, Kiselev OI, Lobzin YV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects. European heart journal. 2007;28(10):1205-10.
12. Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959–1999. American journal of epidemiology. 2004;160(5):492-502.
13. Warren-Gash C, Bhaskaran K, Hayward A, Leung GM, Lo S-V, Wong C-M, et al. Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. Journal of Infectious Diseases. 2011;203(12):1710-8.
14. Acosta E, Hallman SA, Dillon LY, Ouellette N, Bourbeau R, Herring DA, et al. Determinants of influenza mortality trends: Age-period-cohort analysis of influenza mortality in the United States, 1959–2016. Demography. 2019;56(5):1723-46.
15. García‐Lledó A, Rodríguez‐Martín S, Tobías A, García‐de‐Santiago E, Ordobás‐Gavín M, Ansede‐Cascudo JC, et al. Relationship between influenza, temperature, and type 1 myocardial infarction: An ecological time‐series study. Journal of the American Heart Association. 2021;10(8):e019608.
16. Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR. Acute myocardial infarction and influenza: a meta-analysis of case–control studies. Heart. 2015;101(21):1738-47.
17. Warren-Gash C, Hayward AC, Hemingway H, Denaxas S, Thomas SL, Timmis AD, et al. Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. Journal of Infectious Diseases. 2012:jis597.
18. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. New England Journal of Medicine. 2018;378(4):345-53.
19. Warren-Gash C, Blackburn R, Whitaker H, McMenamin J, Hayward AC. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. European Respiratory Journal. 2018;51(3).
20. Caldeira D, Rodrigues B, David C, Costa J, Pinto FJ, Ferreira JJ. The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series. Expert review of vaccines. 2019;18(11):1211-7.
21. Harris JE, Shah PJ, Korimilli V, Win H. Frequency of troponin elevations in patients with influenza infection during the 2017–2018 influenza season. IJC Heart & Vasculature. 2019;22:145-7.
22. Fröbert O, Götberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, et al. Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial. Circulation. 2021;144(18):1476-84.
23. Ciszewski A, Bilinska ZT, Brydak LB, Kepka C, Kruk M, Romanowska M, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. European heart journal. 2008;29(11):1350-8.
24. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation. 2002;105(18):2143-7.
25. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study: One-year follow-up. European Heart Journal. 2004;25(1):25-31.
26. Ciccacci F, Orlando S, Majid N, Marazzi C. Epidemiological transition and double burden of diseases in low-income countries: the case of Mozambique. The Pan African Medical Journal. 2020;37.
27. Zaman RU, Alamgir A, Rahman M, Azziz-Baumgartner E, Gurley ES, Sharker MAY, et al. Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007–2008. PloS one. 2009;4(12).
28. Ahmed M, M.A. Aleem, K. Roguski, J. Abedin, A. Islam, K.F. Alam, E.S. Gurley, M. Rahman, E. Azziz-Baumgartner, N. Homaira, K. Sturm-Ramirez, and A.D. Iuliano. Estimates of seasonal influenza-associated mortality in Bangladesh, 2010-12. Influenza and Other Respiratory Viruses. 2017;in press.
29. Haast B, O’Brien P. Population Trends and Issues. Education About Asia. 2019;24(1).
30. MacIntyre CR, Heywood AE, Kovoor P, Ridda I, Seale H, Tan T, et al. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart. 2013;99(24):1843-8.
31. Annex A, Annex B, Annex C. Recommendations and laboratory procedures for detection of avian influenza A (H5N1) virus in specimens from suspected human cases.
32. MacIntyre CR, Wang Q, Seale H, Yang P, Shi W, Gao Z, et al. A randomized clinical trial of three options for N95 respirators and medical masks in health workers. American journal of respiratory and critical care medicine. 2013;187(9):960-6.
33. MacIntyre CR, Seale H, Dung TC, Hien NT, Nga PT, Chughtai AA, et al. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ open. 2015;5(4):e006577.
34. Porter DD, Porter HG. Respiratory viral antigens in autopsy lung tissue specimens from patients with cancer or myocardial infarction. Clinical infectious diseases. 1999;29(2):437-40.
35. Blackburn R, Zhao H, Pebody R, Hayward A, Warren-Gash C. Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004–2015. Clinical Infectious Diseases. 2018;67(1):8-17.
36. Ohland J, Warren-Gash C, Blackburn R, Mølbak K, Valentiner-Branth P, Nielsen J, et al. Acute myocardial infarctions and stroke triggered by laboratory-confirmed respiratory infections in Denmark, 2010 to 2016. Eurosurveillance. 2020;25(17):1900199.
37. Organization WH. World Health Organization; [Available from: https://www.who.int/tools/flunet.
38. Warren-Gash C, Geretti AM, Hamilton G, Rakhit RD, Smeeth L, Hayward AC. Influenza-like illness in acute myocardial infarction patients during the winter wave of the influenza A H1N1 pandemic in London: a case–control study. BMJ open. 2013;3(5):e002604.
39. Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. European heart journal. 2008;29(1):96-103.
40. Corrales-Medina VF, Alvarez KN, Weissfeld LA, Angus DC, Chirinos JA, Chang C-CH, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. Jama. 2015;313(3):264-74.
41. Guan X, Yang W, Sun X, Wang L, Ma B, Li H, et al. Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction. Inflammation research. 2012;61(6):591-8.
42. Organization WH. Global epidemiological surveillance standards for influenza. 2014. 2017.
43. Chughtai AA, Tan TC, Hitchen EM, Kunasekaran M, MacIntyre CR. Association of influenza infection and vaccination with cardiac biomarkers and left ventricular ejection fraction in patients with acute myocardial infarction. IJC Heart & Vasculature. 2020;31:100648.
44. Wolf YI, Nikolskaya A, Cherry JL, Viboud C, Koonin E, Lipman DJ. Projection of seasonal influenza severity from sequence and serological data. PLoS currents. 2010;2.
45. Muscente F, De Caterina R. Causal relationship between influenza infection and risk of acute myocardial infarction: pathophysiological hypothesis and clinical implications. European Heart Journal Supplements. 2020;22(Supplement_E):E68-E72.
46. Liberale L, Badimon L, Montecucco F, Lüscher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease: JACC review topic of the week. Journal of the American College of Cardiology. 2022;79(8):837-47.
47. Baccarelli A, Benjamin EJ. Triggers of Myocardial Infarction for the Individual and in the Community. Lancet. 2011;377(9767):694.
48. Kloner RA. Natural and unnatural triggers of myocardial infarction. Progress in cardiovascular diseases. 2006;48(4):285-300.
49. Mohammad MA, Tham J, Koul S, Rylance R, Bergh C, Erlinge D, et al. Association of acute myocardial infarction with influenza: A nationwide observational study. PloS one. 2020;15(8):e0236866.
50. Lechner I, Reindl M, Metzler B, Reinstadler SJ. Predictors of Long-Term Outcome in STEMI and NSTEMI—Insights from J-MINUET. MDPI; 2020. p. 3166.
51. Hallén J. Troponin for the estimation of infarct size: what have we learned? Cardiology. 2012;121(3):204-12.
52. Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. Journal of the American College of Cardiology. 2006;48(11):2192-4.
53. Adak A, Devi A, Gupta PK. Influence of Pro-and Anti-inflammatory Cytokines during Pathogenesis Atherosclerosis: A Dynamical Approach. 2022.
54. Veizades S, Tso A, Nguyen PK. Infection, inflammation and thrombosis: A review of potential mechanisms mediating arterial thrombosis associated with influenza and severe acute respiratory syndrome coronavirus 2. Biological Chemistry. 2022;403(2):231-41.
55. Carty CL, Heagerty P, Nakayama K, McClung EC, Lewis J, Lum D, et al. Inflammatory response after influenza vaccination in men with and without carotid artery disease. Arteriosclerosis, thrombosis, and vascular biology. 2006;26(12):2738-44.
56. MacIntyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016;102(24):1953-6.
57. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B, Group FS. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions the FLU vaccination acute coronary syndromes (FLUVACS) study. Circulation. 2002;105(18):2143-7.
58. Gurfinkel E, de la Fuente RL, Beck E, Mendiz O, Toledo D, Arechavala L, et al. 2493 Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study: 1-year follow-up. European Heart Journal. 2003;5(24):469.
59. Bermúdez-Fajardo A, Oviedo-Orta E. Influenza vaccination promotes stable atherosclerotic plaques in apoE knockout mice. Atherosclerosis. 2011;217(1):97-105.
60. Atoui R, Ebrahim F, Saroka K, Mireau J, McElhaney JE, Hare GM. Influenza vaccination blunts the inflammatory response in patients undergoing cardiopulmonary bypass. The Annals of Thoracic Surgery. 2021;111(6):1923-30.